Historical record - last NADAC effective date: 1/1/2019
Product Information
ENSTILAR 0.005%-0.064% FOAM is a brand product labeled by LEO Pharma Inc., priced at $16.7274 per GM under NDC 50222030266. Its NADAC has been published 152 times since Apr 20, 2016.
FDA first approved this application on Oct 16, 2015.
The High Outlier badge above means this manufacturer's average price in the calcipotriene and betamethasone dipropionate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5; 50 mg/g; ug/g
Manufacturer
LEO Pharma Inc.NDC
50222030266
Classification
Brand
Dosage Form
AEROSOL, FOAM
Route
TOPICAL
Effective Date
1/1/2019
Active Ingredients
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE MONOHYDRATEApproval Type
New Drug (NDA)
FDA Application
NDA207589FDA Approved
10/16/2015
On Market Since
10/16/2015
Pharmacological Classes
Price Statistics
The NADAC for ENSTILAR 0.005%-0.064% FOAM has been published 152 times since Apr 20, 2016, and over the history we have for it it has risen 25.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.7274 per GM |
|---|---|
| All-time high | $16.7274 (Mar 13, 2019) |
| All-time low | $13.3095 (May 18, 2016) |
| Median price | $14.5502 |
| Average price | $14.8020 |
| Largest weekly change | +9.0% (Jan 10, 2018) |
| Weeks tracked | 152 |
| Tracking since | Apr 20, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+25.4%
Last surveyed Mar 13, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the calcipotriene and betamethasone dipropionate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ENSTILAR 0.005%-0.064% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for ENSTILAR 0.005%-0.064% FOAM, manufactured by LEO Pharma Inc., is $16.7274 per GM (NDC 50222030266), effective Mar 13, 2019.
How has the price of ENSTILAR 0.005%-0.064% FOAM changed over time?
Over the history we have for it, the NADAC for ENSTILAR 0.005%-0.064% FOAM has risen 25.4%. It has been tracked across 152 weekly CMS publications since Apr 20, 2016.
What are the highest and lowest recorded NADAC prices for ENSTILAR 0.005%-0.064% FOAM?
Since Apr 20, 2016, the NADAC for ENSTILAR 0.005%-0.064% FOAM has ranged from a low of $13.3095 (May 18, 2016) to a high of $16.7274 (Mar 13, 2019), with a median of $14.5502 per GM.
Are there cheaper alternatives to ENSTILAR 0.005%-0.064% FOAM?
No other NADAC-published product currently shares the active ingredient and strength of ENSTILAR 0.005%-0.064% FOAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ENSTILAR 0.005%-0.064% FOAM?
ENSTILAR 0.005%-0.064% FOAM (NDC 50222030266) is labeled by LEO Pharma Inc., and CMS classifies it as a brand product.